The pharmacology of consciousness
Consciousness, Neurochemistry, Neuropharmacology and seminar by Prof. Olivia Carter, Melbourne School of Psychological Sciences
Hosted by Tubingen Neuro Campus
Thursday 11:00–12:10 Berlin (GMT+1)
Ended
Abstract
My research uses a range of methods to better understand how the brain’s natural chemicals control complex behaviours, thoughts and perceptions. I also have a particular fascination about the factors that determine the contents of an individual’s conscious experience. In this talk I will present work that sits at the intersection of these two research areas looking at the role of different neurotransmitter systems in driving changes in conscious state. Specifically, I will discuss a series of studies using ambiguous stimuli to explore the neuropharmacological processes that underly alternations in perceptual awareness. By comparing different methods and neurotransmitter systems including: serotonin (psychedelics), noradrenaline (pupillometry) and Glutamate/GABA (Magnetic Resonance Spectroscopy MRS) we can start to tease apart the distinct role that different neurotransmitter systems play in coordinating conscious experience across time.
Topics
Related seminars
- Video · 57 min · Apr 15, 2021Olivia Carter, The university of Melbourne
Towards a Translational Neuroscience of Consciousness
Video · Mar 25, 2021Hakwan Lau, UCLA Psychology DepartmentConsciousness and the brain: comparing and testing neuroscientific theories of consciousness
Video · 59 min · Feb 20, 2024Liad Mudrik, Tel Aviv University
More from Tubingen Neuro Campus
All talksCause & Consequences of neuronal Tau protein ‘activation’
Jul 17, 2025Susanne WegmannThe reinstatement of a forgotten infantile memory
Jul 10, 2025Flavio DonatoIs it Time for MS Patients to Receive Cognitive Rehabilitation?
Jul 3, 2025John DeLucaFunctional Imaging of the Human Brain: A Window into the Organization of the Human Mind
Jun 26, 2025Nancy Kanwisher
Upcoming in Consciousness
All seminarsEndogenous noise may explain brain state transitions
Dec 1, 2026Axel Hutt